Weight Loss Moved Two Sperm Parameters, Not the Other Two

On two of the four parameters, in the one place it has been measured properly, yes. In a randomised trial (n = 56 men with obesity, BMI 32 to 43), an 8-week 800 kcal per day diet produced a mean weight loss of 16.5 kg (95% CI 15.2 to 17.8). In that randomised cohort, sperm concentration rose 1.49-fold (95% CI 1.18 to 1.88) and total sperm count 1.41-fold (CI 1.07 to 1.87).

Semen volume, sperm motility and motile sperm count did not change. At 52 weeks the improvement was still there in the men who had kept the weight off, and gone in the men who had regained it.

Three honest limits on that. It is 56 men. The semen analysis was a preregistered exploratory part of a trial designed to test weight-loss maintenance, and the authors write that definite inferences cannot be made. And nobody measured whether a pregnancy followed. The trial was funded by the Novo Nordisk Foundation, which also supplied the drug and placebo used in the maintenance phase.

This is the part most often got wrong, including by the earlier version of this page. The largest analysis -- 21 studies pooled with unpublished data, 13,077 men from both the general population and fertility clinics -- found that mean sperm concentration did NOT differ significantly across BMI categories.

What did differ was the chance of falling into the very low or absent bracket. Versus men of normal weight, the pooled odds ratio for oligozoospermia or azoospermia was 1.11 (95% CI 1.01 to 1.21) in overweight men, 1.28 (CI 1.06 to 1.55) in obese men and 2.04 (CI 1.59 to 2.62) in morbidly obese men. The relationship is a shift in the tail, not a shift in everyone's average.

A separate meta-analysis pooled 44 studies including 20,367 men with obesity and does report mean differences versus non-obese controls: sperm count lower by 23.84 million (95% CI -30.36 to -17.33), concentration lower by 7.26 million per mL (CI -10.07 to -4.46), progressive motility lower by 5.68 percentage points (CI -8.79 to -2.56) and total testosterone lower by 1.11 nmol/L (CI -1.92 to -0.30). Its own authors state that the number and quality of the included studies is limited and that the conclusions need verification by higher-quality work.

NICE puts the clinical version in one line. NG257 1.9.3: inform men with a BMI of 30 kg/m2 or over that they have an increased risk of reduced fertility. That is the whole male recommendation on obesity -- a risk statement, not a target. For the female side, see weight and female fertility.

This is the largest and most consistent effect on the page. Across 24 pooled trials, a low-calorie diet raised total testosterone by 2.87 nmol/L (95% CI 1.68 to 4.07) and bariatric surgery by 8.73 nmol/L (CI 6.51 to 10.95), both versus baseline. Weight loss also lowered estradiol and raised gonadotrophin levels.

The size of the rise tracked the size of the weight loss, and was larger in younger men, men without diabetes, and men with more weight to lose. Degree of weight loss was the single best predictor.

A number moving is not the same as fertility improving. A testosterone result is worth interpreting in context rather than chasing -- and taking testosterone as a medicine does the opposite of what people expect, because it suppresses sperm production. NG257 1.13.1 lists testosterone-replacement therapy among the drugs a clinician should ask about in anyone concerned about fertility. See what a low testosterone result means and what testosterone therapy costs fertility.

This is the counterweight, and it is important enough to state carefully. LIFEstyle randomised 577 obese infertile women, BMI 29 or higher, to either six months of a lifestyle programme followed by 18 months of infertility treatment, or to prompt infertility treatment for 24 months.

The primary outcome was narrow and specific: the vaginal birth of a healthy singleton at term within 24 months of randomisation. It occurred in 27.1% of the lifestyle arm versus 35.2% of the prompt-treatment arm (rate ratio 0.77, 95% CI 0.60 to 0.99). Mean weight loss was 4.4 kg in the lifestyle arm versus 1.1 kg in the control arm; 21.8% of the lifestyle arm discontinued.

Read it as what it is. This is a trial of sequencing -- lose weight first, or start now -- inside a fixed 24-month window, and the control arm had six more months of treatment time inside that window. It is not a finding that losing weight harms fertility, and it was not done in men. Nothing comparable has been run in men.

The paper carries a published erratum (New England Journal of Medicine 2018;378(26):2546). Its existence is confirmed on the record; its content could not be retrieved for this page, so what it corrects is unknown here and no figure above should be treated as final without checking it.

About three months. One cycle of sperm production was measured directly in 11 men who drank labelled water for three weeks: labelled sperm appeared in the ejaculate after 64 plus or minus 8 days, with an individual range of 42 to 76 days.

NICE NG257 1.17.4 sets the same clock for the test itself -- repeat confirmatory semen tests “ideally 3 months after the initial analysis to allow time for the cycle of spermatozoa formation to be completed” -- with one exception in the same recommendation: if azoospermia or severe oligozoospermia has been found, repeat the test as soon as possible rather than waiting.

And under NG257 1.17.5, two or more abnormal analyses should lead to a physical examination of the scrotum and testes and consideration of serum testosterone and gonadotrophin measurement. Weight is worth changing; it is not a substitute for that. See how to read a semen analysis report.

Stated plainly, because the opposite of each of these appeared on the earlier version of this page:

• That being underweight harms male fertility. In the pooled 13,077-man analysis the underweight odds ratio for oligozoospermia or azoospermia was 1.15 (95% CI 0.93 to 1.43) -- not significant. NICE NG257's low-body-weight recommendation, 1.10.1, is written for women only and has no male counterpart.
• That body fat raises scrotal temperature enough to impair sperm production. Not retrievable. NG257 1.11.1 records the temperature association while stating it is uncertain whether even wearing loose-fitting underwear improves fertility, so the better-studied version of the question is unresolved.
• That leptin resistance is the mechanism. Asserted widely, not retrievable.
• That insulin resistance acts on the hypothalamic-pituitary-gonadal axis. The retrievable diabetes data is an association with semen parameters, not a demonstrated pathway.
• That there is a BMI number at which male fertility normalises. No such figure was retrievable. NG257 gives a risk threshold of 30 kg/m2, not a target.
• That a semen parameter improving means a pregnancy follows. The weight-loss trial did not measure pregnancy or live birth. The only randomised outcome data on lifestyle change before treatment is LIFEstyle, in women, and it went the other way.
• That weight loss reverses obesity-related subfertility. A 2023 systematic review of 112 articles concludes that lifestyle interventions generally appear to improve male fertility markers while calling the picture for drugs and surgery mixed, and calls for further research. That is a hedge, not a result.

1. If your BMI is 30 or over, that is the threshold NG257 attaches a fertility risk to, and weight loss is the one intervention with randomised semen data behind it.
2. Expect the concentration and count to be where any change shows. Motility and volume did not move in the trial, so do not read a flat motility figure as failure.
3. Retest at about three months, not sooner -- unless the first analysis showed azoospermia or severe oligozoospermia, in which case NG257 1.17.4 says repeat it straight away.
4. Do not postpone the work-up to do this first. That is the one thing a randomised trial has tested, in women, and the arm that waited had fewer healthy term births inside the same 24-month window.
5. If you are being sent for treatment, ask whether weight is actually the finding or just the visible thing. Sometimes the answer is testing, timing or a simpler treatment.

Two related pages: male fertility and diabetes and sleep apnoea and fertility, both of which travel with weight and neither of which this page asserts a mechanism for.

Most men reading this have already been told to lose weight, usually without being told what it would change or how long it would take. The measured answer is narrower than the advice: two parameters out of four, in 56 men, over about three months, with no pregnancy outcome attached. That is worth knowing before you carry the instruction around as a verdict on yourself.